Navigation Links
Cosmetic Surgery - No Killer Blood Clots to the Lungs Sans GA, PK Anesthesia Can Save the Day
Date:2/3/2009

CORONA DEL MAR, Calif., Feb. 3 /PRNewswire/ -- Plastic & Reconstructive Surgery (PRS) Journal, the leading journal in the field, published the remarkable safety record of propofol ketamine (PK) anesthesia this month - no killer blood clots to the lungs (pulmonary embolism or PE) of the more than 4,000 patients over the past 16 years! This series included several hundred tummy-tuck patients.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090203/LA64906)

PRS published last year that PK's safety record contrasted sharply with general anesthesia (GA) for tummy tuck patients with 23 patient deaths over 5 years. Motionlessness associated with GA is a significant factor for lethal PE, according to The Doctors Company, a medical malpractice insurer founded by plastic surgeons. www.thedoctors.com/risk/specialty/anesthesiology/J4254.asp

Death from cosmetic surgery is never acceptable. www.medicalnewstoday.com/articles/71223.php

Motionlessness from GA contributes to relaxation believed by many surgeons to be essential to perform a tummy tuck. Along with relaxation comes sludging of blood in the pelvic veins that contributes to the formation of potentially deadly blood clots.

Many other surgeons understand all that is needed to safely perform tummy tucks is adequate local anesthesia. However, injecting the local anesthesia is painful. Most patients do not want to hear, feel or remember their surgery - an experience they associate with GA.

Dr. Barry Friedberg developed the PK intravenous sedation technique to bridge the safety gap between purely local anesthesia (i.e. safest) and GA (i.e. highest, unnecessary and avoidable risk).

Using the BIS to monitor the patient's individual brain response guides precise propofol dosing so the patient is first asleep before the ketamine is given. Then, the local anesthesia can be injected WITHOUT pain. While the patient's body receives adequate local anesthesia, the mind does not hear, feel or remember the experience.

With BIS monitored PK anesthesia the patient gets what she (or he) wants from the GA experience while avoiding the risks of GA.

In addition to avoiding all of the risks of GA, patients report increased satisfaction with PK over their experiences with GA, especially those who have had difficulty waking up or those who have had nausea or vomiting. www.cosmeticsurgeryanesthesia.com/testimonials3.htm

For more information about PK anesthesia or Cosmetic Surgery Anesthesia please visit www.cosmeticsurgeryanesthesia.com

Disclaimer: Dr. Friedberg is not an employee, stockholder or paid consultant of Aspect Medical Systems, Inc., makers of the BIS monitor.


'/>"/>
SOURCE Cosmetic Surgery Anesthesia
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cosmetic Surgery & Exotic Brazil
2. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
3. Safer, Simpler, Better & Cost Effective Cosmetic Surgery Anesthesia
4. Study Shows Cosmetic Surgery on the Rise as Safety and Efficacy of Procedures Increase
5. Plastic Surgery 2007: Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances
6. Whole Foods Market(R) Helps Shoppers Understand the Benefits of Natural Cosmetics
7. Prominent Cosmetic Dentist Dr. William Hoskyns Joins Leading Atlanta Practice
8. Cosmetic Surgeons Gather in Dubai for World Congress, Hospital Opening
9. Statement by John Bailey, EVP for Science Cosmetic, Toiletry, and Fragrance Association on Campaign for Safe Cosmetics Report on Lead in Lipstick
10. Cosmetic Bootcamp Solidifies Lead as Investor Symposium for Aesthetic Medicine
11. Health Groups Call on Cosmetic Giant LOreal to Remove Lead From Lipstick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... DrugDev ... announcement that it is one of the early adopters completing EU-U.S. Privacy Shield Certification ... designed to provide companies on both sides of the Atlantic with a mechanism to ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... celebrating the passage of the most comprehensive mental health systems reform legislation in ... support of the President, and the commitment of our elected officials to improving ...
(Date:12/7/2016)... York, NY (PRWEB) , ... December 07, 2016 ... ... amounts of the drug in their bodies, a researcher at the Icahn School ... journal Pediatric Research. , The study found that when young children are exposed ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... of Smart Device Remote Control through a new partnership with Splashtop Inc. This ... strengthens its mobile solutions to help businesses maximize their uptime and productivity. , ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has announced ... report to their offering. ... , The report provides separate comprehensive ... , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology: